Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.400
+0.210 (6.58%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Perspective Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| Revenue | 1.24 | 1.45 | 1.43 | 5.42 | - | 10.05 | Upgrade
|
| Revenue Growth (YoY) | -15.64% | 1.40% | -73.52% | - | - | 3.85% | Upgrade
|
| Cost of Revenue | 52.32 | 39.43 | 20.34 | 3.05 | - | 4.93 | Upgrade
|
| Gross Profit | -51.09 | -37.98 | -18.91 | 2.37 | - | 5.12 | Upgrade
|
| Selling, General & Admin | 30.77 | 26.61 | 21.06 | 9.35 | 5.57 | 7.13 | Upgrade
|
| Research & Development | 3.54 | 2.21 | 0.97 | 1.81 | 0.85 | 1.43 | Upgrade
|
| Operating Expenses | 34.31 | 28.82 | 22.03 | 11.17 | 6.42 | 8.56 | Upgrade
|
| Operating Income | -85.4 | -66.8 | -40.94 | -8.8 | -6.42 | -3.44 | Upgrade
|
| Interest Expense | -0.24 | -0.05 | -0.08 | - | - | - | Upgrade
|
| Interest & Investment Income | 10.77 | 10.52 | 0.93 | 0.62 | 0.12 | 0.06 | Upgrade
|
| Earnings From Equity Investments | -0 | -0.01 | -0.02 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.4 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -73.48 | -56.34 | -40.11 | -8.18 | -6.3 | -3.38 | Upgrade
|
| Impairment of Goodwill | -24.06 | -24.06 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.03 | -0.03 | - | -0.31 | - | -0.01 | Upgrade
|
| Pretax Income | -97.56 | -80.43 | -40.11 | -8.49 | -6.3 | -3.39 | Upgrade
|
| Income Tax Expense | -2.1 | -2.1 | -2.65 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -95.47 | -78.33 | -37.46 | -8.49 | -6.3 | -3.39 | Upgrade
|
| Earnings From Discontinued Operations | 0.51 | -0.95 | -9.05 | -2.28 | -0.97 | - | Upgrade
|
| Net Income | -94.95 | -79.28 | -46.51 | -10.76 | -7.27 | -3.39 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0 | Upgrade
|
| Net Income to Common | -94.95 | -79.28 | -46.51 | -10.76 | -7.27 | -3.39 | Upgrade
|
| Shares Outstanding (Basic) | 72 | 64 | 27 | 14 | 14 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 72 | 64 | 27 | 14 | 14 | 10 | Upgrade
|
| Shares Change (YoY) | 67.21% | 140.72% | 88.38% | 0.06% | 36.73% | 53.61% | Upgrade
|
| EPS (Basic) | -1.32 | -1.23 | -1.74 | -0.76 | -0.51 | -0.33 | Upgrade
|
| EPS (Diluted) | -1.32 | -1.23 | -1.74 | -0.76 | -0.51 | -0.33 | Upgrade
|
| Free Cash Flow | -114.78 | -72.71 | -37.99 | -10.68 | -7.98 | -3.22 | Upgrade
|
| Free Cash Flow Per Share | -1.59 | -1.13 | -1.42 | -0.75 | -0.56 | -0.31 | Upgrade
|
| Gross Margin | - | - | - | 43.71% | - | 50.94% | Upgrade
|
| Operating Margin | -6914.98% | -4594.02% | -2855.02% | -162.47% | - | -34.19% | Upgrade
|
| Profit Margin | -7688.50% | -5452.48% | -3243.24% | -198.71% | - | -33.72% | Upgrade
|
| Free Cash Flow Margin | -9294.25% | -5000.55% | -2648.88% | -197.28% | - | -32.01% | Upgrade
|
| EBITDA | -82.56 | -64.5 | -40.23 | -8.48 | -6.14 | -3.23 | Upgrade
|
| EBITDA Margin | - | - | - | -156.56% | - | -32.10% | Upgrade
|
| D&A For EBITDA | 2.84 | 2.3 | 0.71 | 0.32 | 0.28 | 0.21 | Upgrade
|
| EBIT | -85.4 | -66.8 | -40.94 | -8.8 | -6.42 | -3.44 | Upgrade
|
| EBIT Margin | - | - | - | -162.47% | - | -34.19% | Upgrade
|
| Revenue as Reported | - | - | - | 5.42 | - | - | Upgrade
|
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.